"Prospective Feasibility Trial of AccuCath 2.25 Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department"

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions
Vascular Access Complication
Interventions
DEVICE

"AccuCath 2.25 BC Intravascular Catheter"

Long peripheral IV catheter designed for difficult IV access patients requiring deeper vessel access, often used with ultrasound guidance.

Trial Locations (1)

11030

North Shore - Long Island Jewish Health System, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02449798 - "Prospective Feasibility Trial of AccuCath 2.25 Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department" | Biotech Hunter | Biotech Hunter